TROG Cancer Research
Members Login   CQMS Login

TROG 02.03

Primary sponsor: TROG
Collaborating group: Urological Society of Australasia


Efficacy study of adding chemotherapy to radiotherapy for treating bladder cancer


Radiation and chemotherapy both work in people with muscle-invasive bladder cancer. This study will determine if giving them together improves the results for people with this disease that seems to be confined to the bladder, but who are felt to be suitable candidates for bladder preserving treatment.

Final accrual


Trial Status

Closed to follow-up, February 2010

Trial chairpersons

Dr Kumar Gogna, QRI Mater Centre, QLD

Trial contact

Kumar Gogna

Further information

TROG 02.03 on the Australian Cancer Trials Register

Trial resources for TROG members

TROG 02.03 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.